Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Electric dreams in medicine

Treating human disease with electrical impulses dates back decades, and now pharma is exploring the concept of ‘electroceuticals’ to complement drug-based therapy

- PMLiVE

FDA suspends sale of Ariad’s cancer drug

Iclusig linked to increased risk of blood clots

Bayer symbol

Bayer buoyant as new products drive pharma

Xarelto, Stivarga, Eylea and Xofigo all perform will in third quarter

- PMLiVE

FDA creates drug shortage plan

Manufacturers required to give early notice of potential shortfall of important medicines

- PMLiVE

To name and shame substandard healthcare?

Improving care by ‘naming and shaming’ hospitals or doctors remains a thorny issue

- PMLiVE

AZ names Dunoyer as CFO

He succeeds Simon Lowth as company restructure continues apace

Novartis building

Novartis weighs in on biosimilar naming debate

Files petition urging FDA to keep system where biosimilars share a name with the original drug

- PMLiVE

Change at the top as Levin leaves Teva

CEO resigns amid company-wide restructure

- PMLiVE

Janssen submits blood cancer drug in EU

Seeks EMA approval for ibrutinib

- PMLiVE

Former Ketchum head joins Luther Pendragon

Avril Lee becomes director at the corporate communications consultancy

- PMLiVE

AZ takes severe asthma antibody into phase III

Benralizumab shows promise in clinical trials

Shire appoints finance-focused board member

Dominic Blakemore is group finance director of Compass Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links